The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Vivek Ramaswamy, Elon Musk’s partner in an effort to cut government costs, could make decisions that ultimately make him and his investors richer.

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.